News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28672)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3204)
October (3539)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (215)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Policy
Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm
The Court ordered Onxeo to pay SpeBio for costs incurred before termination the sum of 8.6 million euros with capitalized interest at the legal rate as of June 30, 2014.
October 18, 2017
·
5 min read
Business
Invuity Strengthens Senior Management With Appointment of Chief Human Resources Officer
Ms. Fish was most recently the Chief Human Resources Officer for Marlin Equity Partners, a private equity firm.
October 18, 2017
·
2 min read
Business
Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast
Management will host a conference call on that date at 10:00 a.m. EDT to discuss these results and provide an update on the company.
October 18, 2017
·
1 min read
Policy
Neos Therapeutics Announces Settlement with Actavis on Adzenys XR-ODT Patent Litigation
Under the agreement, Neos has granted Actavis the right to manufacture and market its generic version of Adzenys XR-ODT under the Actavis ANDA beginning on September 1, 2025, or earlier under certain circumstances.
October 18, 2017
·
3 min read
Business
Gritstone Oncology and Arbutus Biopharma Announce LNP Technology Licensing Agreement to Develop Novel RNA-Based Personalized Neoantigen Immunotherapies for Cancer Patients
Arbutus is deploying its proprietary lipid nanoparticle (LNP) technology to deliver Gritstone’s RNA-based neoantigen immunotherapy products.
October 18, 2017
·
5 min read
GENEWIZ Launches Expanded Next Generation Sequencing Services Including Quick-Turn Amplicon-EZ and Long-Read Amplicon Sequencing at ASHG
ASHG17, Booth #323 -- Leading global genomics service provider, GENEWIZ, launches CLIA Sanger sequencing and new NGS amplicon sequencing, at booth #323 during The American Society of Human Genomics (ASHG) Annual Meeting.
October 18, 2017
·
3 min read
Business
Genomics Plc Teams Up With Biogen To Discover New Drug Targets For Multiple Sclerosis
Genomics PLC today announced that it has entered into a collaborative deal with Biogen.
October 18, 2017
·
3 min read
Drug Development
Mutabilis Joins The European ENABLE Consortium To Fight Antibiotic Resistance
Mutabilis announces its selection by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria.
October 18, 2017
·
5 min read
Business
Pharmazz has Received Exclusive License to U.S. Patent for Treatment of Opioid Tolerance And Pain Management
Pharmazz has received exclusive license to U.S. patent for treatment of opioid tolerance and pain management. Inadequate pain control is a major public health concern in the USA.
October 18, 2017
·
2 min read
Pharm Country
Qosina Announces Donation To Puerto Rico For Hurricane Relief Efforts
Qosina, a leading global supplier of stock components to the medical OEM and pharmaceutical industries, today announced that it has donated funds to aid in the relief efforts of hurricane-ravaged Puerto Rico.
October 18, 2017
·
1 min read
Previous
12 of 15
Next